L-Cysteine Hydrochloride (Sandoz Inc)
Welcome to the PulseAid listing for the L-Cysteine Hydrochloride drug offered from Sandoz Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | L-Cysteine Hydrochloride |
SUBSTANCE NAME: | CYSTEINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2016-06-14 |
END MARKETING DATE: | 0000-00-00 |
L-Cysteine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | L-Cysteine Hydrochloride from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2016-06-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-8940_40e63e07-1f05-4dd9-af32-d40cbfb463e5 |
PRODUCT NDC: | 0781-8940 |
APPLICATION NUMBER: | |
Other CYSTEINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: